Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry Van Dyke

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Nature Medicine|September 9, 2010
Finding the tumor copycat: approximating a human cancerTerry Van Dyke
The New England Journal of Medicine|January 5, 2007
p53 and tumor suppressionTerry Van Dyke
Nature|March 18, 2005
Cancer biology: sense out of missenseTerry Van Dyke
Cell|February 8, 2002
Cancer modeling in the modern era: progress and challengesTerry Van Dyke, Tyler Jacks
Pigment Cell & Melanoma Research|March 14, 2012
β-catenin in metastatic melanoma--the smoking gun reloadedTerry Van Dyke, Glenn Merlino
Cell|November 6, 2008
It takes a (dysfunctional) village to raise a tumorKarlyne M Reilly, Terry Van Dyke
Cell|June 2, 2007
Stopping ras in its tracksChanning J Der, Terry Van Dyke
Idrugs : the Investigational Drugs Journal|April 1, 2009
Advances in Prostate Cancer Research--AACR Special Conference In Cancer ResearchSheri L Kuslak, Terry Van Dyke
Cell|September 26, 2015
Preclinical mouse cancer models: a maze of opportunities and challengesChi-Ping Day, Glenn Merlino, Terry Van Dyke
Molecular and Cellular Biology|August 19, 2005
A dominant interfering Bub1 mutant is insufficient to induce or alter thymic tumorigenesis in vivo, even in a sensitized genetic backgroundDale O Cowley, Ginger W Muse, Terry Van Dyke
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Nature Medicine|September 9, 2010
Finding the tumor copycat: approximating a human cancerTerry Van Dyke
The New England Journal of Medicine|January 5, 2007
p53 and tumor suppressionTerry Van Dyke
Nature|March 18, 2005
Cancer biology: sense out of missenseTerry Van Dyke
Cell|February 8, 2002
Cancer modeling in the modern era: progress and challengesTerry Van Dyke, Tyler Jacks
Pigment Cell & Melanoma Research|March 14, 2012
β-catenin in metastatic melanoma--the smoking gun reloadedTerry Van Dyke, Glenn Merlino
Cell|November 6, 2008
It takes a (dysfunctional) village to raise a tumorKarlyne M Reilly, Terry Van Dyke
Cell|June 2, 2007
Stopping ras in its tracksChanning J Der, Terry Van Dyke
Idrugs : the Investigational Drugs Journal|April 1, 2009
Advances in Prostate Cancer Research--AACR Special Conference In Cancer ResearchSheri L Kuslak, Terry Van Dyke
Cell|September 26, 2015
Preclinical mouse cancer models: a maze of opportunities and challengesChi-Ping Day, Glenn Merlino, Terry Van Dyke
Molecular and Cellular Biology|August 19, 2005
A dominant interfering Bub1 mutant is insufficient to induce or alter thymic tumorigenesis in vivo, even in a sensitized genetic backgroundDale O Cowley, Ginger W Muse, Terry Van Dyke
Pageof 7